Table I.
Characteristics of the clinical trial included in the review (LOD/Gonadotropins)
| Author/Year | Patient (N) | Age (year) | BMI (kg/m 2 ) | Duration of trial (month) | Outcomes |
|---|---|---|---|---|---|
| F. Mehrabian/ 2012 (16) | 104 (52/52) | 29.17 ± 5.47 28.51 ± 5.51 |
27.73 ± 6.16 27.55 ± 6.07 |
3/3 | - Pregnancy - Multiple pregnancies - Miscarriage |
| M. Ghafarnegad/ 2010 (14) | 100 (50/50) | 26.8 ± 3.3 26 ± 3.5 |
28.4 ± 4.2 28.1 ± 6 |
4/4 | - Pregnancy - Live birth - Miscarriage |
| H. Kaya/ 2005 (15) | 35 (17/18) | 26.3 ± 4.3 25.6 ± 4.08 |
27.4 ± 4.2 26.3 ± 3.2 |
6/6 | - Pregnancy - Multiple pregnancies |
| N. Bayram/ 2004 (12) | 168 (83/85) | 28.5 ± 3.7 28.7 ± 4.1 |
27.9 ± 6.3 27.3 ± 8.8 |
12/12 | - Pregnancy - Live birth - Multiple pregnancies - Miscarriage |
| C.M.Farquhar/ 2002 (13) | 50 (29/21) | 29.6 ± 4.7 29.6 ± 4.2 |
28.3 ± 3.9 27.8 ± 4.8 |
6/3 | - Pregnancy - Live birth - Multiple pregnancies - Miscarriage |
| M. Vicino/ 2000 (17) | 42 (21/21) | 29.8 ± 3.2 28.1 ± 3.4 |
30.3 ± 3.1 30.4 ± 3.9 |
12/12 | - Pregnancy |